Pharma leaders came ready to engage and strengthen the industry at the 2017 Pharma Market Research Conference (PMRC) in February in Parsippany, New Jersey. The annual event always attracts a crowd, but this year the enthusiasm and energy was off the charts. Over the course of two days, attendees got to interact with hundreds of senior-level executives from 100+ companies, while discussing and debating the future of market research.
The event began with dynamic keynotes featuring two influential industry leaders who shared their thoughts and experience. Clive Meanwell, CEO, The Medicines Company, led a talk called “Innovation, Value and Price: Any Link?” and Barry Greene, President, Alnylam Pharmaceuticals, presented “Building a Biopharmaceutical Company for the Future—the Importance of Patient Insight.” Attendees found the presentations engaging, informative, and inspirational.
Interactive roundtables and multiple track sessions ensured that everyone in attendance was able to take away something from the event. Topics ranged from a wide spectrum of industry issues, and some highlights involved expanding market research to boost actionable insight, leveraging social media and ethnography, and the difficulties of forecasting in a continuously changing market.
The Pharma Market Research Conference remains the premier gathering of senior-level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research. Stay tuned for the 2018 PMRC. Meanwhile, up next is the West Coast for the Bay Area Pharma Market Research Conference at the Le Mèridien Hotel in San Francisco, June 13-14 2017. More details at: http://pharmamarketresearchconference.com.
